Singapore markets closed

Healios K.K. (6VX.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.8900+0.0550 (+6.59%)
As of 08:05AM CET. Market open.

Healios K.K.

Hibiya Mitsui Tower
12 floor WORK STYLING 1-1-2 Yurakucho Chiyoda-ku
Tokyo 100-0006
Japan

https://www.healios.co.jp

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Tadahisa S. Kagimoto M.D.Chairman & CEON/AN/A1976
Mr. Richard P. KincaidCFO, Executive Officer & Internal DirectorN/AN/A1976
Mr. Masanori Sawada M.D., MBA, Ph.D.Executive VP, Chief Medical Officer and In Charge of Development & Human Resources & General AffairsN/AN/A1981
Mr. Kouichi Tamura Ph.D.Exec. Off., Chief Scientific Off., In Charge of Res. & Manufacturing and Head of Kobe Res. InstituteN/AN/A1956
Mr. Yoshinari MatsudaManaging DirectorN/AN/A1978
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.

Corporate governance

Healios K.K.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.